KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants

BACKGROUND: Patients diagnosed for a serous ovarian borderline tumor (s-BOT) typically present with an excellent clinical outcome. However there have been controversies concerning the prognostic impact of so-called implants, an extra ovarian spread occurring alongside the s-BOT in certain cases. It...

Descripción completa

Detalles Bibliográficos
Autores principales: Heublein, Sabine, Grasse, Katinka, Hessel, Harald, Burges, Alexander, Lenhard, Miriam, Engel, Jutta, Kirchner, Thomas, Jeschke, Udo, Mayr, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015926/
https://www.ncbi.nlm.nih.gov/pubmed/24139521
http://dx.doi.org/10.1186/1471-2407-13-483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015926/
https://www.ncbi.nlm.nih.gov/pubmed/24139521
http://dx.doi.org/10.1186/1471-2407-13-483

Ejemplares similares